Biosimilar Versus Urinary Gonadotropins

PHASE4UnknownINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions

Infertility

Interventions

DRUG

Biosimilar recombinant FSH

Controlled ovarian stimulation with 150 IU/day biosimilar recombinant FSH

DRUG

Urinary FSH

Controlled ovarian stimulation with 150 IU/day urinary FSH

Trial Locations (1)

IVI Madrid, Madrid